Disclaimer
Pharma Studies Policies · Privacy
Privacy Statement
The International Journal of Pharma Studies respects the privacy of authors, reviewers, editors, and other users of the journal. This Privacy Statement explains how the journal collects, uses, stores, and protects personal information in connection with its website, manuscript submission, peer-review, editorial, and publishing activities.
1. Information We Collect
Depending on your interaction with the journal, we may collect the following types of information:
Personal and Contact Information
- Name
- Email address
- Telephone number, where required
- Postal or correspondence address, where required
Professional and Academic Information
- Institutional affiliation
- Department or designation
- Country
- Academic or professional information relevant to the manuscript or editorial process
- ORCID iD and other researcher identifiers, where provided
Account and Submission Information
- Username and account details
- Manuscript title, abstract, keywords, and manuscript files
- Author and co-author information
- Affiliations and corresponding author details
- Cover letters, declarations, references, figures, tables, and supplementary files
- Research-related information submitted as part of the editorial process, including relevant pharmaceutical, laboratory, drug development, pharmacological, toxicological, or clinical research materials
Peer-Review and Editorial Information
- Reviewer and editor details
- Reviewer reports and recommendations
- Editorial comments and decisions
- Correspondence relating to manuscripts, peer review, and publication
Publication and Payment Information
- Information required for publication processing
- Billing and invoicing details
- Information relating to applicable publication charges or other journal-related payments
Technical Information
Where collected through the website or submission system, the journal may process limited technical information such as IP address, browser type, device information, and access or server logs for website operation, security, and administration.
2. How We Use Personal Information
The journal uses personal information for legitimate journal and publishing purposes, including to:
- Create and manage user accounts
- Receive and process manuscript submissions
- Conduct editorial assessment and peer review
- Communicate with authors, reviewers, editors, and other users
- Process accepted manuscripts for publication
- Manage applicable publication charges and related administration
- Maintain accurate editorial and publication records
- Support research integrity and the scholarly record
- Operate, maintain, and secure the journal website and submission system
- Handle relevant research-integrity concerns involving pharmaceutical data, clinical research information, or publication ethics
The journal does not sell or rent personal information or use it for unrelated commercial marketing purposes.
3. Information Published with Articles
When an article is accepted and published, certain information becomes part of the public scholarly record. This may include the authors’ names, institutional affiliations, country, ORCID iDs where provided, and corresponding author information.
Publication of this information supports proper attribution, authorship identification, discoverability, and scholarly communication.
Authors should ensure that manuscripts and supplementary materials do not disclose identifiable patient information or other confidential personal data without an appropriate legal basis, required permissions, and applicable ethical safeguards. Where clinical studies, patient records, or human-participant research are involved, authors are responsible for following relevant ethics, consent, confidentiality, and data-protection requirements.
4. Confidentiality
Personal information obtained during manuscript submission, peer review, and editorial processing is handled with appropriate confidentiality.
Unpublished manuscripts, confidential reviewer reports, editorial communications, proprietary pharmaceutical research information, and non-public clinical or laboratory data must be handled responsibly and must not be disclosed or used for unauthorized purposes.
Reviewer and editorial information is not publicly disclosed except where disclosure is consistent with the journal’s policies, necessary for legitimate publishing activities, or required by applicable law.
5. Third-Party Services
The journal may use appropriate third-party services to support journal operations, including manuscript submission and peer review, website and technical services, DOI and publication services, payment processing, communication, indexing or abstracting, and digital preservation.
Where personal information is shared with such service providers, only information necessary for the relevant service or legitimate journal purpose is intended to be provided, subject to applicable agreements and legal requirements.
Authors, reviewers, and editors should avoid submitting confidential patient information or other sensitive personal data to third-party tools or services unless their use is authorized and appropriate safeguards are in place.
6. Data Protection and Retention
The journal takes reasonable technical and organizational measures to protect personal information against unauthorized access, disclosure, alteration, loss, or misuse.
Personal information may be retained for as long as necessary to support editorial administration, publication activities, research integrity, legal or administrative requirements, and the maintenance of the scholarly record.
Information relating to clinical studies, patients, human participants, or confidential pharmaceutical research should be handled in accordance with applicable ethical, confidentiality, and data-protection requirements.
7. Correction of Personal Information
Authors, reviewers, editors, and other users may contact the Editorial Office of the International Journal of Pharma Studies if they believe that their personal information is inaccurate, incomplete, or requires updating.
Requests will be considered in accordance with applicable requirements and the journal’s recordkeeping obligations.
8. Updates and Contact
The journal may update this Privacy Statement when necessary to reflect changes in journal operations, publishing practices, technology, or applicable requirements. The latest version published on the journal website will apply.
For questions regarding the collection, use, protection, or correction of personal information, please contact the Editorial Office of the International Journal of Pharma Studies through the official contact details provided on the journal website.
This Privacy Statement should be read together with the Terms and Conditions, Copyright and Licensing, and other relevant policies of the International Journal of Pharma Studies.